Market view: ASEAN-6 pharma equipment import structure, 2026
ASEAN-6 pharma equipment imports projected at USD 1.24B in 2026. China's share rises from 22% (2024) to 31% (2026), led by filling and packaging.
This market view combines customs data from 6 countries, association reports, and platform inquiry data. All 2026 numbers are estimates against the 2024 baseline.
Total: USD 1.24B, +14% YoY
- Indonesia USD 420M (+18% YoY)
- Vietnam USD 280M (+21% YoY)
- Thailand USD 200M (+9% YoY)
- Malaysia USD 140M (+12% YoY)
- Philippines USD 120M (+15% YoY)
- Singapore USD 80M (+6% YoY)
Country structure: China is rising
Indonesia is still China's largest market (47% of China's ASEAN exports), but Vietnam is catching up at 50%+ YoY growth. Malaysia and the Philippines remain Germany/Japan-dominated (~60% combined), representing the next medium-term opportunity.
Category opportunities: Filling > Tablet press > Cleanroom
Chinese makers hold a clear price advantage in filling and packaging — quotes average 55–65% of German/Japanese pricing. Combined with BPOM/DAV mutual-recognition lanes, these stay the 2026 primary battlegrounds. Tablet press and cleanroom face higher technical bars; Chinese makers need to invest in IQ/OQ/PQ validation documentation.
Sources & methodology
Sources: 6-country customs (UN COMTRADE) + ASEAN pharma associations + 1,200+ platform inquiries. Estimated margin of error ±8%; will be revised against actual contract data in H2 2026.